This trial is !
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Infant, Small for Gestational Age
and you are
between 4 and 16
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

A study demonstrates the non-inferiority of DA-3002 when compared with Genotropin® in short children born small for gestational age.

Provided treatments

  • Drug: DA-3002
  • Drug: Genotropin®
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02770157. The sponsor of the trial is Dong-A ST Co., Ltd. and it is looking for 75 volunteers for the current phase.
Official trial title:
Phase III Clinical Trial for Assessment of Efficacy and Safety of DA-3002 (Recombinant Human Growth Hormone) in Short Children Born Small for Gestational Age.